Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000769993-21-000164
Filing Date
2021-02-16
Accepted
2021-02-16 15:37:26
Documents
1
Group Members
GOLDMAN SACHS GROUP, INC.

Document Format Files

Seq Description Document Type Size
1 T2 13G AMENDMENT T2_FINAL.txt SC 13G/A 45922
  Complete submission text file 0000769993-21-000164.txt   47552
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 2129021000
GOLDMAN SACHS & CO. LLC (Filed by) CIK: 0000769993 (see all company filings)

EIN.: 135108880 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Subject) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88541 | Film No.: 21637279
SIC: 3841 Surgical & Medical Instruments & Apparatus